Cargando…
Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
While improved tumor treatment has significantly reduced the overall mortality rates, invasive progression including recurrence, therapy resistance and metastasis contributes to the majority of deaths caused by cancer. Enhancers are essential distal DNA regulatory elements that control temporal- or...
Autores principales: | Zboril, Emily, Yoo, Hannah, Chen, Lizhen, Liu, Zhijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488287/ https://www.ncbi.nlm.nih.gov/pubmed/34616687 http://dx.doi.org/10.3389/fonc.2021.753051 |
Ejemplares similares
-
Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
por: Zhao, Yue, et al.
Publicado: (2023) -
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
por: Civenni, Gianluca, et al.
Publicado: (2019) -
BaBao Dan Suppresses Tumor Growth of Pancreatic Cancer Through Modulating Transcriptional Reprogramming of Cancer-Related Genes
por: Song, Libin, et al.
Publicado: (2020) -
Cancer-Induced Reprogramming of Host Glucose Metabolism: “Vicious Cycle” Supporting Cancer Progression
por: Schwartsburd, Polina
Publicado: (2019) -
High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
por: Huang, Lijun, et al.
Publicado: (2021)